Capstone Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Capstone Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$109K	Sell	14,630 -690	-5%	-$4.51K	﹤0.01%	1568
2017 Q1	$100K	Sell	15,320 -1,960	-11%	-$11K	﹤0.01%	1588
2016 Q4	$77K	Buy	17,280 +110	+0.6%	+$461	﹤0.01%	1601
2016 Q3	$80K	Sell	17,170 -190	-1%	-$1.13K	﹤0.01%	1588
2016 Q2	$114K	Buy	17,360 +10	+0.1%	+$71	﹤0.01%	1576
2016 Q1	$110K	Sell	17,350 -1,440	-8%	-$7.39K	﹤0.01%	1555
2015 Q4	$113K	Buy	18,790 +80	+0.4%	+$458	﹤0.01%	1574
2015 Q3	$112K	Buy	18,710 +1,410	+8%	+$9.79K	﹤0.01%	1564
2015 Q2	$118K	Sell	17,300 -7,880	-31%	-$50K	﹤0.01%	1589
2015 Q1	$153K	Buy	25,180 +290	+1%	+$1.93K	﹤0.01%	1615
2014 Q4	$172K	Sell	24,890 -4,130	-14%	-$30.4K	0.01%	1599
2014 Q3	$236K	Sell	29,020 -450	-2%	-$3.52K	0.01%	1491
2014 Q2	$240K	Buy	29,470 +1,487	+5%	+$11.3K	0.01%	1506
2014 Q1	$219K	Sell	27,983 -470	-2%	-$3.98K	0.01%	1613
2013 Q4	$252K	Sell	28,453 -8,630	-23%	-$77.1K	0.01%	1643
2013 Q3	$311K	Buy	37,083 +810	+2%	+$6.56K	0.01%	1643
2013 Q2	$271K	Buy	+36,273	New	+$278K	0.01%	1636

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capstone Asset Management's SPPI Position: Q2 2017 in Review

Capstone Asset Management reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 4.5% in Q2 2017, selling an estimated $4.51K and leaving 14,630 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Capstone Asset Management first reported a position in SPPI in Q2 2013 and has held it in 17 quarters since. The position peaked at $311K in Q3 2013. 124 funds tracked by Wall St. Rank hold SPPI as of Q2 2017.

Capstone Asset Management held 14,630 shares of Spectrum Pharmaceuticals Inc worth $109K as of Q2 2017.
Capstone Asset Management sold 690 Spectrum Pharmaceuticals Inc shares in Q2 2017, an estimated $4.51K.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1568 holding.
Capstone Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's Spectrum Pharmaceuticals Inc position peaked at $311K in Q3 2013.
124 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.